Ultra-rapid Opiate Detoxification Using Deep Sedation and Prior Oral Buprenorphine Preparation.
NCT01008072 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2009-11-05
Summary
The methods of detoxification under general anesthesia have been criticized because of limited data on safety and long-term follow-up. Premedication with buprenorphine has been advocated to improve safety. In current study we want to evaluate the importance of buprenorphine preparation in rapid opioid detoxification process, under general anesthesia.
Conditions
Sponsors & Collaborators
-
Assaf-Harofeh Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-12-31
- Primary Completion
- 2009-12-31
Countries
- Israel
More Related Trials
-
Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1
NCT00032955 ·Status: COMPLETED ·Phase: PHASE3
-
Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1
NCT00032968 ·Status: COMPLETED ·Phase: PHASE3
-
Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids
NCT00218101 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine Pharmacology Related to Addiction Treatment - 21
NCT00000239 ·Status: COMPLETED ·Phase: PHASE2
-
Extended-release Injectable Buprenorphine for Individuals at High Risk of Overdose
NCT04815590 ·Status: UNKNOWN
-
Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence
NCT00134914 ·Status: COMPLETED ·Phase: NA
-
Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers
NCT00134875 ·Status: TERMINATED ·Phase: NA
-
Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine Microdosing
NCT05307458 ·Status: UNKNOWN
-
Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
NCT01841931 ·Status: TERMINATED ·Phase: PHASE4
-
Pupillometry and Pain Thresholds Patients Substituted by Methadone and Buprenorphine
NCT01560442 ·Status: UNKNOWN
-
Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults
NCT01046539 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Three Opioid Detoxification Treatment Regimens
NCT03678792 ·Status: WITHDRAWN ·Phase: PHASE3
-
Treatment of Polydrug-Using Opiate Dependents During Withdrawal
NCT00367874 ·Status: COMPLETED ·Phase: PHASE4
-
Alternate-Day Buprenorphine Administration. Phase IV - 5
NCT00000223 ·Status: COMPLETED ·Phase: PHASE2
-
Nalrexone Facilitated Discontinuation of Buprenorphine
NCT01895036 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users
NCT00158236 ·Status: COMPLETED ·Phase: NA
-
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000355 ·Status: COMPLETED ·Phase: PHASE1
-
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718 ·Status: RECRUITING ·Phase: PHASE4
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone
NCT02294253 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder
NCT06086275 ·Status: COMPLETED ·Phase: PHASE1
-
Opiate Craving Reduction Study Using Post-detox Patients on Suboxone and Use of TEAS as Adjunctive Treatment
NCT02033746 ·Status: WITHDRAWN ·Phase: NA
-
Buprenorphine Maintenance for Opiate Dependence - 6
NCT00000357 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms
NCT04091009 ·Status: WITHDRAWN ·Phase: PHASE4
-
Alternate-Day Buprenorphine Administration. Phase II - 4
NCT00000222 ·Status: COMPLETED ·Phase: PHASE1